From £7.99 per month
ShareProphets
The one stop source for breaking news, expert analysis, and podcasts on fast-moving AIM and LSE listed shares

MINDING THE LSE’S BUSINESS

Join for as low as £7.99 per month

With ShareProphets’ membership, you receive:

• All premium articles

• Tom Winnifrith’s Bearcast

• Access to all the entire nearly 10 year archive

• ShareProphets Daily Newsletter

KERBOOM: Ouzo at Sheriff Towers – it is essentially game over at Purplebricks

By Tom Winnifrith, the Sheriff of AIM | Tuesday 9 May 2023


Disclosure: I have no positions in any stocks mentioned, and no plans to initiate any positions within the next 72 hours. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from ShareProphets). I have no business relationship with any company whose stock is mentioned in this article.


Neil Woodford and Thirsty Paul Scott took the knee at the disruptive potential of online estate agent Purplebricks (PURP). In latter years the deadwood press blew smoke up the arses of the CEO and CFO as they were both women. Girl Power! More ESG vicar? Of course, the numbers never stacked up and the fundamental business offering was dire so shareholders and customers both got screwed. Those of us who do actually look at how a business runs and at hard numbers may be sexist old dinosaurs for doing so but we have another win. Today’s fess up from the birds in charge is grim.
Premium content is for paid subscribers only
ShareProphets is reader-supported journalism

Become a member starting at £6.99 per month for all articles, the Bearcast, and our seven year archive.


Filed under:



Subscribe to our newsletter

Daily digest of our latest stories.



Search ShareProphets

Market News

Complete Coverage

Recent Comments

That Was the Week that Was

 

AAU

Gold up Ariana down

Saturday »

AVCT

Cassava, A warning to Avacta Sharehoders 

Friday »

ALU

Alumasc Group – a growth Buy

 

VCP

Victoria - The roll up unravels

 

HEMO

Hemogenyx is a short – target 0p

 

ECR

ECR, the timing is unfortunate

 

APH

Alliance Pharma – a recovery Buy?

Time left: 17:34:51